Jane Berkelhammer

520 total citations
23 papers, 426 citations indexed

About

Jane Berkelhammer is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Jane Berkelhammer has authored 23 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Immunology and 10 papers in Oncology. Recurrent topics in Jane Berkelhammer's work include Immunotherapy and Immune Responses (7 papers), Cutaneous Melanoma Detection and Management (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Jane Berkelhammer is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Cutaneous Melanoma Detection and Management (6 papers) and Viral Infectious Diseases and Gene Expression in Insects (5 papers). Jane Berkelhammer collaborates with scholars based in United States. Jane Berkelhammer's co-authors include Ronald W. Oxenhandler, R R Hook, Michael J. Mastrangelo, Robert E. Bellet, Wallace H. Clark, A. Bodurtha, Saul Malkiel, Richmond T. Prehn, Karin U. Loeffler and L Feeney-Burns and has published in prestigious journals such as The Journal of Immunology, Cancer and International Journal of Cancer.

In The Last Decade

Jane Berkelhammer

23 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane Berkelhammer United States 12 170 168 137 72 61 23 426
Marcia L. Padilla United States 11 118 0.7× 121 0.7× 163 1.2× 87 1.2× 109 1.8× 13 474
Marilyn B. Budmen United States 7 165 1.0× 112 0.7× 94 0.7× 19 0.3× 27 0.4× 7 322
Kozo Ohkusu‐Tsukada Japan 12 135 0.8× 206 1.2× 235 1.7× 16 0.2× 37 0.6× 36 515
Fazal H. Tabassam United States 12 182 1.1× 64 0.4× 255 1.9× 30 0.4× 39 0.6× 15 480
Hermann-Josef Gröne Germany 9 98 0.6× 103 0.6× 228 1.7× 27 0.4× 36 0.6× 9 496
S G Irving United States 6 210 1.2× 104 0.6× 203 1.5× 14 0.2× 39 0.6× 11 445
Meera S. Paranjpe United States 10 97 0.6× 114 0.7× 133 1.0× 37 0.5× 70 1.1× 15 402
Jean‐Claude Ehrhart France 11 35 0.2× 194 1.2× 364 2.7× 50 0.7× 50 0.8× 20 503
Gretchen N. Schwartz United States 15 237 1.4× 172 1.0× 210 1.5× 9 0.1× 77 1.3× 33 616
Adrianne N. Hanks United States 8 134 0.8× 136 0.8× 347 2.5× 81 1.1× 23 0.4× 9 472

Countries citing papers authored by Jane Berkelhammer

Since Specialization
Citations

This map shows the geographic impact of Jane Berkelhammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Berkelhammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Berkelhammer more than expected).

Fields of papers citing papers by Jane Berkelhammer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Berkelhammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Berkelhammer. The network helps show where Jane Berkelhammer may publish in the future.

Co-authorship network of co-authors of Jane Berkelhammer

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Berkelhammer. A scholar is included among the top collaborators of Jane Berkelhammer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Berkelhammer. Jane Berkelhammer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berkelhammer, Jane, et al.. (2013). Impact of antioxidants on the ability of phenolic phytochemicals to kill HCT116 colon cancer cells. Free Radical Research. 48(3). 313–321. 6 indexed citations
2.
Berkelhammer, Jane, et al.. (1986). Phenotypic instability of mouse melanomas after propagation in vivo and in vitro.. PubMed. 46(6). 2923–8. 16 indexed citations
3.
Hook, R R, Carl V. Hamby, Larry E. Millikan, et al.. (1983). Cell‐mediated immune reactivity of sinclair melanoma‐bearing swine to 3 M KC1 extracts of swine and human melanoma. International Journal of Cancer. 31(5). 633–637. 8 indexed citations
4.
Burns, Robert P., et al.. (1983). Uveitis caused by cytotoxic immune response to cutaneous malignant melanoma in swine: destruction of uveal melanocytes during tumor regression.. PubMed. 24(8). 1063–9. 18 indexed citations
5.
Berkelhammer, Jane, et al.. (1982). Growth and spontaneous regression of swine melanoma: relationship of in vitro leukocyte reactivity.. PubMed. 68(3). 461–8. 24 indexed citations
6.
Hook, R R, Jane Berkelhammer, & Ronald W. Oxenhandler. (1982). Melanoma: Sinclair swine melanoma.. PubMed. 108(1). 130–3. 40 indexed citations
7.
Berkelhammer, Jane, et al.. (1982). Development of a new melanoma model in C57BL/6 mice.. PubMed. 42(8). 3157–63. 67 indexed citations
8.
Oxenhandler, Ronald W., et al.. (1982). Growth and regression of cutaneous melanomas in Sinclair miniature swine.. PubMed. 109(3). 259–69. 36 indexed citations
9.
Berkelhammer, Jane & R R Hook. (1980). GROWTH OF SINCLAIR SWINE MELANOMA IN THE HAMSTER CHEEK POUCH1. Transplantation. 29(3). 193–195. 9 indexed citations
10.
Berkelhammer, Jane, et al.. (1979). Adaptation of Sinclair swine melanoma cells to long-term growth in vitro.. PubMed. 39(12). 4960–4. 12 indexed citations
11.
Berkelhammer, Jane, Michael J. Mastrangelo, Robert E. Bellet, David Berd, & Richmond T. Prehn. (1979). Chemoimmunotherapy increases the lymphocyte reactivity of melanoma patients. European Journal of Cancer (1965). 15(2). 197–204. 4 indexed citations
13.
Bellet, Robert E., et al.. (1976). A Study of Antitumor (Phase II) and Immunosuppressive Effects of ICRF‐159 in Patients with Metastatic Melanoma. The Journal of Clinical Pharmacology. 16(8-9). 433–438. 2 indexed citations
14.
15.
Berkelhammer, Jane, et al.. (1975). Sequential in vitro reactivity of lymphocytes from melanoma patients receiving immunotherapy compared with the reactivity of lymphocytes from healthy donors. International Journal of Cancer. 16(4). 571–578. 20 indexed citations
16.
Mastrangelo, Michael J., Robert E. Bellet, Jane Berkelhammer, & Wallace H. Clark. (1975). Regression of pulmonary metastatic disease associated with intralesional bcg therapy of intracutaneous melanoma metastases. Cancer. 36(4). 1305–1308. 49 indexed citations
17.
Berkelhammer, Jane. (1974). In vitro testing in tumor immunotherapy.. PubMed. 1(4). 397–408. 3 indexed citations
18.
Berkelhammer, Jane & M. J. Freeman. (1972). Secondary Antibody Response Elicitedin vitrowith Chicken γ Globulin. Immunological Communications. 1(4). 337–350. 1 indexed citations
19.
Malkiel, Saul, et al.. (1970). Immunologically induced aspermatogenesis in the white mouse. Journal of Allergy. 46(6). 321–325. 1 indexed citations
20.
Malkiel, Saul, et al.. (1968). Immunologically Induced Aspermatogenesis in the White Mouse. The Journal of Immunology. 101(2). 374–376. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026